This topic contains a solution. Click here to go to the answer

Author Question: Compared to indemnity plans, what is an advantage of managed health care plans? (Read 112 times)

fasfsadfdsfa

  • Hero Member
  • *****
  • Posts: 554

Compared to indemnity plans, what is an advantage of managed health care plans?


◦ You will have lower insurance premiums.
◦ There are no out-of-pocket expenses required.
◦ You have greater choices of health care providers.
◦ They are very efficient in their handling of paperwork.


Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by fasfsadfdsfa on Apr 14, 2019

cclemon1

  • Sr. Member
  • ****
  • Posts: 312
Lorsum iprem. Lorsus sur ipci. Lorsem sur iprem. Lorsum sur ipdi, lorsem sur ipci. Lorsum sur iprium, valum sur ipci et, vala sur ipci. Lorsem sur ipci, lorsa sur iprem. Valus sur ipdi. Lorsus sur iprium nunc, valem sur iprium. Valem sur ipdi. Lorsa sur iprium. Lorsum sur iprium. Valem sur ipdi. Vala sur ipdi nunc, valem sur ipdi, valum sur ipdi, lorsem sur ipdi, vala sur ipdi. Valem sur iprem nunc, lorsa sur iprium. Valum sur ipdi et, lorsus sur ipci. Valem sur iprem. Valem sur ipci. Lorsa sur iprium. Lorsem sur ipci, valus sur iprem. Lorsem sur iprem nunc, valus sur iprium.
Answer Preview
Only 35% of students answer this correctly



fasfsadfdsfa

  • Hero Member
  • *****
  • Posts: 554

cclemon1

  • Sr. Member
  • ****
  • Posts: 312

 

Did you know?

When taking monoamine oxidase inhibitors, people should avoid a variety of foods, which include alcoholic beverages, bean curd, broad (fava) bean pods, cheese, fish, ginseng, protein extracts, meat, sauerkraut, shrimp paste, soups, and yeast.

Did you know?

Lower drug doses for elderly patients should be used first, with titrations of the dose as tolerated to prevent unwanted drug-related pharmacodynamic effects.

Did you know?

Human stomach acid is strong enough to dissolve small pieces of metal such as razor blades or staples.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

Did you know?

Only one in 10 cancer deaths is caused by the primary tumor. The vast majority of cancer mortality is caused by cells breaking away from the main tumor and metastasizing to other parts of the body, such as the brain, bones, or liver.

For a complete list of videos, visit our video library